Original Articles: Rhinitis, Sinusitis, and Upper Airway Disease
To add the references below to your reference management program: 1. Download the file; 2. Open your reference management program or EndNote; 3. Select File and import |
71 Articles |
-
Epigenetic responses to rhinovirus exposure in airway epithelial cells are correlated with key transcriptional pathways in chronic rhinosinusitis
Soliai, MM, Kato, A, Naughton, KA, et al. Allergy. First published: 12 August 2023
-
Dupilumab-induced eosinophilia in patients with diffuse type 2 chronic rhinosinusitis
Ryser, FS, Yalamanoglu, A, Valaperti, A, et al. Allergy. First published: 07 August 2023
-
Two-year results of tapered dupilumab for CRSwNP demonstrates enduring efficacy established in the first 6 months
van der Lans, RJL, Otten, JJ, Adriaensen, GFJPM, et al. Allergy. First published: 02 July 2023
-
Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): a multicentric observational phase 4 real-life study (DUPIREAL)
De Corso, E., Pasquini, E., Trimarchi, M., et al. Allergy. First published: 18 May 2023
-
Sinus inflammation and chronic rhinosinusitis are associated with a diagnosis of new onset asthma in the following year
Schwartz, BS, Pollak, JS, Bandeen-Roche, K, et al. Allergy. First published: 17 May 2023
-
IL-4 drastically decreases deuterosomal and multiciliated cells via alteration in progenitor cell differentiation
Cho, H-J, Chung, YW, Moon, S, et al. Allergy. First published: 08 March 2023
-
Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK-air® longitudinal study
Sousa-Pinto, B, Schünemann, HJ, Sá-Sousa, A, et al. Allergy. First published: 03 November 2022
-
Predicting dupilumab treatment outcome in patients with primary diffuse type 2 chronic rhinosinusitis
Soyka, M.B., Ryser, F.S., Brühlmann, C., et al. Allergy. First published: 26 September 2022
-
Validated allergen exposure chamber is plausible tool for assessment of house dust mite-triggered allergic rhinitis
Zemelka-Wiacek, M., Kosowska, A., Winiarska, E., et al. Allergy. First published: 18 August 2022
-
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): in-depth sinus surgery analysis
Fokkens, W.J., Mullol, J., Kennedy, D., et al. Allergy. First published: 13 July 2022
Sequential class switch recombination to IgE and allergen-induced accumulation of IgE+ plasmablasts occur in the nasal mucosa of local allergic rhinitis patients
Testera-Montes, A., Palomares, F., Jurado-Escobar, R., et al. Allergy. First published: 27 March 2022
Transcriptomics of rhinovirus persistence reveals sustained expression of RIG-I and interferon-stimulated genes in nasal epithelial cells in vitro
Ong, H.H., Andiappan, A.K., Duan, K., et al. Allergy. First published: 10 March 2022
Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air® real-world data
Sousa-Pinto, B., Sá-Sousa, A., Vieira, R.J., et al. Allergy. First published: 08 March 2022
The prevalence of non-allergic rhinitis phenotypes in the general population: a cross-sectional study
Avdeeva, K.S., Fokkens, W.J., Segboer, C.L. and Reitsma, S. Allergy. First published: 17 January 2022
Dupilumab improves health-related quality of life in severe chronic rhinosinusitis with nasal polyps
Lee, S.E., Hopkins, C., Mullol, J. et al. Allergy. First published: 16 January 2022
Development and validation of combined symptom-medication scores for allergic rhinitis
Sousa-Pinto, B., Filipe Azevedo, L., Jutel, M., et al. Allergy. First published: 21 December 2021
Predicting the recurrence of chronic rhinosinusitis with nasal polyps using nasal microbiota
Zhao, Y, Chen, J, Hao, Y, et al. Allergy. First published: 04 November 2021
miR-146a enhances regulatory T-cell differentiation and function in allergic rhinitis by targeting STAT5b
Zhang, Y, Yang, Y, Guo, J, et al. Allergy. First published: 30 October 2021
CD103 integrin identifies a high IL-10-producing FoxP3+ regulatory T cell population suppressing allergic airway inflammation
Tagkareli, S., Salagianni, M., Galani, I.-E., et al. Allergy. First published: 17 October 2021
Large-scale provocation studies identify maladaptive responses to ubiquitous aeroallergens as a correlate of severe allergic rhinoconjunctivitis and asthma
Smith, A.M., Ramirez, R.M., Harper, N., et al. Allergy. First published: 04 October 2021
A scalable and highly immunogenic virus-like particle-based vaccine against SARS-CoV-2
Mohsen, MO, Balke, I, Zinkhan, S, et al. Allergy. First published: 08 September 2021
Efficacy and safety of dupilumab in patients with uncontrolled severe CRSwNP and a clinical diagnosis of NSAID-ERD: Results from two randomized placebo-controlled phase 3 trials
Mullol, J., Laidlaw, T.M., Bachert, C., et al. Allergy. First published: 30 August 2021
Association between mucosal barrier disruption by pseudomonas aeruginosa exoproteins and asthma in patients with chronic rhinosinusitis
Tuli, J.F., Ramezanpour, M., Cooksley, C., Psaltis, A.J., Wormald, P.-J. and Vreugde, S. Allergy. First published: 25 May 2021
The maternal diet index in pregnancy is associated with offspring allergic diseases: the Healthy Start study
Venter, C, Palumbo, MP, Glueck, DH, et al.Allergy. First published: 22 May 2021
Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus
Hagemann, J., Onorato, G.L., Jutel, M., et al. Allergy. First published: 17 March 2021
Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS-52 is unaffected by eosinophilic status
Fujieda, S, Matsune, S, Takeno, S, et al.Allergy. First published: 16 May 2021
Overcoming bacteriophage insensitivity in staphylococcus aureus using clindamycin and azithromycinat subinhibitory concentrations
Liu, S., Zhao, Y., Hayes, A., Allergy. 2021; 76: 3446-3458
Heterogeneity of pollen food allergy syndrome in seven Southern European countries: the @IT.2020 multicenter study
Lipp, T., Acar Şahin, A., Aggelidis, X., et al. Allergy. 2021; 76: : 3041-3052
Prevalence and early-life risk factors of school-age allergic multimorbidity: The EuroPrevall-iFAAM birth cohort
Sigurdardottir, ST, Jonasson, K, Clausen, M, et al. Allergy. 2021; 76: 2855– 2865
Effect of intranasal corticosteroid treatment on allergen-induced changes in group 2 innate lymphoid cells in allergic rhinitis with mild asthma
Xie, Y., Ju, X., Beaudin, S., et al. Allergy. 2021; 76: 2797-2808
Tear N-glycomics in vernal and atopic keratoconjunctivitis
Messina, A., Palmigiano, A., Tosto, C., et al. Allergy.2021; 76: 2500-2509
Ragweed plants grown under elevated CO2 levels produce pollen which elicit stronger allergic lung inflammation
Rauer, D, Gilles, S, Wimmer, M, et al. Allergy. 2021; 76: 1718-1730
A murine model of eosinophilic chronic rhinosinusitis using the topical application of a vitamin D3 analog
Kagoya, R, Kondo, K, Kishimoto-Urata, M, et al. Allergy. 2021; 76: 1432– 1442
Stromal cells and B cells orchestrate ectopic lymphoid tissue formation in nasal polyps
Wang, Z-Z, Song, J, Wang, H, et al. Allergy. 2021; 76: 1416– 1431
Distinct expression of SARS-CoV-2 receptor ACE2 correlates with endotypes of chronic rhinosinusitis with nasal polyps
Wang, M, Bu, X, Fang, G, et al. Allergy. 2021; 76: 789– 803
Cold-inducible RNA-binding protein contributes to tissue remodeling in chronic rhinosinusitis with nasal polyps
Shi, L-L, Ma, J, Deng, Y-K, et al. Allergy. 2021; 76: 497– 509
A novel whole blood gene expression signature for asthma, dermatitis, and rhinitis multimorbidity in children and adolescents
Lemonnier, N, Melén, E, Jiang, Y, et al. Allergy. 2020; 75: 3248– 3260
Real-life assessment of chronic rhinosinusitis patients using mobile technology: The mySinusitisCoach project by EUFOREA
Seys, SF, De Bont, S, Fokkens, WJ, et al. Allergy. 2020; 75: 2867– 2878
CD23 expression on switched memory B cells bridges T-B cell interaction in allergic rhinitis
Yao, Y, Wang, N, Chen, C-L, et al. Allergy. 2020; 75: 2599– 2612
Tnfaip3 expression in pulmonary conventional type 1 Langerin-expressing dendritic cells regulates T helper 2-mediated airway inflammation in mice
Vroman, H, van Uden, D, Bergen, IM, et al. Allergy. 2020; 75: 2587– 2598
The international sinonasal microbiome study: A multicentre, multinational characterization of sinonasal bacterial ecology
Paramasivan, S, Bassiouni, A, Shiffer, A, et al. Allergy. 2020; 75: 2037– 2049
Artemisia annua-sublingual immunotherapy for seasonal allergic rhinitis: A randomized controlled trial
Lou, H, Huang, Y, Ouyang, Y, et al. Allergy. 2020; 75: 2026– 2036
Orally applied bacterial lysate in infants at risk for atopy does not prevent atopic dermatitis, allergic rhinitis, asthma or allergic sensitization at school age: Follow-up of a randomized trial
Roßberg, S, Keller, T, Icke, K, et al. Allergy. 2020; 75: 2020– 2025
Eleven faces of coronavirus disease 2019
Dong, X, Cao, Y-Y, Lu, X-X, et al. Allergy. 2020; 75: 1699– 1709
Coexistence of nasal reactivity to allergens with and without IgE sensitization in patients with allergic rhinitis
Eguiluz-Gracia, I, Fernandez-Santamaria, R, Testera-Montes, A, et al. Allergy. 2020; 75: 1689– 1698
Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air(®) App
Bédard, A, Antó, JM, Fonseca, JA, et al. Allergy. 2020; 75: 1672– 1688
"Whole" vs. "fragmented" approach to EAACI pollen season definitions: A multicenter study in six Southern European cities
Hoffmann, TM, Acar Şahin, A, Aggelidis, X, et al. Allergy. 2020; 75: 1659– 1671
Macrophage-derived progranulin promotes allergen-induced airway inflammation
Choi, J-P, Park, SY, Moon, K-A, et al. Allergy. 2020; 75: 1133– 1145
Nasal epithelial barrier dysfunction increases sensitization and mast cell degranulation in the absence of allergic inflammation
Kortekaas Krohn, I, Seys, SF, Lund, G, et al. Allergy. 2020; 75: 1155– 1164
Radiologic sinus inflammation and symptoms of chronic rhinosinusitis in a population-based sample
Hirsch, AG, Nordberg, C, Bandeen-Roche, K, et al. Allergy. 2020; 75: 911– 920
Profilin is a marker of severity in allergic respiratory diseases
Ruiz-Hornillos, J, López-Matas, MA, Berges Jimeno, P, et al. Allergy. 2020; 75: 853– 861
Allergic rhinitis and allergic sensitisation are still increasing among Danish adults
Leth-Møller, KB, Skaaby, T, Linneberg, A. Allergy. 2020; 75: 660– 668
Apolipoprotein A-IV acts as an endogenous anti-inflammatory protein and is reduced in treatment-naïve allergic patients and allergen-challenged mice
Roula, D, Theiler, A, Luschnig, P, et al. Allergy. 2020; 75: 392– 402
Evidence for the induction of Th2 inflammation by group 2 innate lymphoid cells in response to prostaglandin D2 and cysteinyl leukotrienes in allergic rhinitis
Tojima, I, Matsumoto, K, Kikuoka, H, et al. Allergy. 2019; 74: 2417– 2426
Determination of the minimally important difference in a nasal symptom score in house dust mite allergy
Devillier, P, Brüning, H, Bergmann, K-C. Allergy. 2019; 74: 2191– 2198
Pollen exposure at birth and adolescent lung function, and modification by residential greenness
Lambert, KA, Lodge, C, Lowe, AJ, et al. Allergy. 2019; 74: 1977– 1984
Google trends and pollen concentrations in allergy and airway diseases in France
Bousquet, J, Onorato, GL, Oliver, G, et al. Allergy. 2019; 74: 1910– 1919
Bronchial asthma triggered by house dust mites in patients with local allergic rhinitis
Campo, P, Eguiluz-Gracia, I, Plaza-Serón, MC, et al. Allergy. 2019; 74: 1502– 1510
Immunotherapy with grass pollen tablets reduces medication dispensing for allergic rhinitis and asthma: A retrospective database study in France
Devillier, P, Molimard, M, Ansolabehere, X, et al. Allergy. 2019; 74: 1317– 1326
Increased expression of L-plastin in nasal polyp of patients with nonsteroidal anti-inflammatory drug-exacerbated respiratory disease
Takabayashi, T, Tanaka, Y, Susuki, D, et al. Allergy. 2019; 74: 1307- 1316
Mobile health tools for the management of chronic respiratory diseases
Sleurs, K, Seys, SF, Bousquet, J, et al. Allergy. 2019; 74: 1292- 1306
Safety and reproducibility of nasal allergen challenge
Eguiluz-Gracia, I, Testera-Montes, A, González, M, et al. Allergy. 2019; 74: 1125– 1134
Dysregulated fatty acid metabolism in nasal polyp-derived eosinophils from patients with chronic rhinosinusitis
Miyata, J, Fukunaga, K, Kawashima, Y, et al. Allergy. 2019; 74: 1113– 1124
Dupilumab reduces local type 2 pro-inflammatory biomarkers in chronic rhinosinusitis with nasal polyposis
Jonstam, K, Swanson, BN, Mannent, LP, et al. Allergy. 2019; 74: 743– 752
The hippo pathway effector Yes-associated protein promotes epithelial proliferation and remodeling in chronic rhinosinusitis with nasal polyps
Deng, H, Sun, Y, Wang, W, et al. Allergy. 2019; 74: 731– 742
Endotypes of chronic rhinitis: A cluster analysis study
Meng, Y, Lou, H, Wang, Y, et al. Allergy. 2019; 74: 720– 730
Disentangling the heterogeneity of allergic respiratory diseases by latent class analysis reveals novel phenotypes
Amaral, R, Bousquet, J, Pereira, AM, et al. Allergy. 2019; 74: 698– 708
Type 2/Th2-driven inflammation impairs olfactory sensory neurogenesis in mouse chronic rhinosinusitis model
Rouyar, A, Classe, M, Gorski, R, et al. Allergy. 2019; 74: 549– 559
Asthma diagnosis using integrated analysis of eosinophil microRNAs
Rodrigo-Muñoz, JM, Cañas, JA, Sastre, B, et al. Allergy. 2019; 74: 507– 517
Atopic diseases and type I sensitization from adolescence to adulthood in an unselected population (TOACS) with focus on predictors for allergic rhinitis
Mortz, CG, Andersen, KE, Poulsen, LK, Kjaer, HF, Broesby-Olsen, S, Bindslev-Jensen, C. Allergy. 2019; 74: 308– 317
Th2 cytokines orchestrate the secretion of MUC5AC and MUC5B in IL-5-positive chronic rhinosinusitis with nasal polyps
Zhang, Y, Derycke, L, Holtappels, G, et al. Allergy. 2019; 74: 131– 140